Crestline Management, L.P.
FORT WORTH, TX
$53m in 3 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 0.4% of the portfolio this quarter.
Value
$53m
Stocks
3
Top 10 share
100.0%
Turnover
0.4%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
- Denali TherapeuticsDNLI91.9% of the fund-14%
Sold out
Sold their entire stake.
None this quarter.
Holdings
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Denali TherapeuticsDNLI | 91.9% | $49m | 1,910,732 | -14% |
| Sana BiotechnologySANA | 4.9% | $3m | 755,736 | Held |
| 8X8EGHT | 3.2% | $2m | 990,850 | Held |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is down 14.5% since 30 June 2025.
Where the money is
Health care96.8%
Technology3.2%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.